반응식
C([O:3][C:4](=[O:27])[CH2:5][S:6][C:7]1[S:8][C:9]([NH:12][C:13]([N:15]([CH:21]2[CH2:26][CH2:25][CH2:24][CH2:23][CH2:22]2)[CH:16]2[CH2:20][CH2:19][CH2:18][CH2:17]2)=[O:14])=[N:10][N:11]=1)C.C1(NC2CCCC2)CCCCC1.C(OC(=O)CSC1SC(N)=NN=1)C>>[CH:21]1([N:15]([CH:16]2[CH2:20][CH2:19][CH2:18][CH2:17]2)[C:13](=[O:14])[NH:12][C:9]2[S:8][C:7]([S:6][CH2:5][C:4]([OH:27])=[O:3])=[N:11][N:10]=2)[CH2:22][CH2:23][CH2:24][CH2:25][CH2:26]1참가 물질
4
반응물 3
생성물 1
실험 절차
[5-(3-Cyclohexyl-3-cyclopentyl-ureido)-[1,3,4]thiadiazol-2-ylsulfanyl]-acetic acid ethyl ester prepared as described in general procedures (A) and (B) using cyclohexyl-cyclopentyl-amine and ethyl-2-[5-amino-1,3,4-thiadiazol-2-yl-thio]acetate. Hydrolysis using general procedure (F) gave the title compound.
후처리
- customHydrolysis
출처 및 근거
- ORD 기록
- ord-228ef38c535443fe9a4cda920493068b
- 출처 데이터셋
- uspto-grants-2011_01
- 특허 번호
- US07872139B2
연결된 노트
불러오는 중…